Here we assess whether CD4:CD8 ratio and CD8 cell counts may be useful biomarkers for the risk of NADM, AIDS-defining malignancies (ADM) and specific cancers, after accounting for known risk factors of cancers and sociodemographic participant characteristics. The gene discussed is CD8A; the disease is cancer.